Ratings changes for Super Micro Computer, Fluence Energy, Healthcare Services Group, Astera Labs, XOMA, Moderna, Expedia Group and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Elon’s Favorite Energy Source Is Incredibly Undervalued-It Trades for Just 40 Cents (ad)
Elon Musk has a bold vision: a future where his favorite energy source powers the world. And he’s not alone. Amazon, Google, Meta, and Microsoft are driving 40% of U.S. demand, signaling that it’s the future.
And the reason why? AI is set to increase global energy consumption by up to 10x, and this energy source is the only one that can meet the demand.
Right now is a unique chance to witness this explosive growth for less than 40 cents.
CEO Mark Zuckerberg sold 55,589 shares of the stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $717.72, for a total value of $39,897,337.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Allient (NASDAQ:ALNT) was upgraded by analysts at Northland Securities from a “market perform” rating to an “outperform” rating. They now have a $35.00 price target on the stock, up previously from $30.00. This represents a 34.6% upside from the current price of $26.01.
Brixmor Property Group (NYSE:BRX) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $31.00 price target on the stock. This represents a 15.6% upside from the current price of $26.82.
Compass (NYSE:COMP) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $11.00 price target on the stock, up previously from $7.00. This represents a 40.4% upside from the current price of $7.83.
First Solar (NASDAQ:FSLR) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $259.00 price target on the stock, up previously from $218.00. This represents a 57.0% upside from the current price of $164.99.
Southwest Airlines (NYSE:LUV) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $35.00 price target on the stock. This represents a 16.9% upside from the current price of $29.93.
monday.com (NASDAQ:MNDY) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $420.00 price target on the stock. This represents a 26.7% upside from the current price of $331.45.
Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $15.00 price target on the stock. This represents a 71.1% upside from the current price of $8.77.
RTX (NYSE:RTX) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $127.98.
Super Micro Computer (NASDAQ:SMCI) was upgraded by analysts at Cfra from a “hold” rating to a “buy” rating. They now have a $48.00 price target on the stock. This represents a 14.5% upside from the current price of $41.94.
Steel Dynamics (NASDAQ:STLD) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $155.00 price target on the stock. This represents a 16.2% upside from the current price of $133.42.
TXNM Energy (NYSE:TXNM) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $54.00 price target on the stock, up previously from $51.00. This represents a 9.8% upside from the current price of $49.17.
Columbus McKinnon (NASDAQ:CMCO) was downgraded by analysts at DA Davidson from a “buy” rating to a “neutral” rating. They now have a $35.00 price target on the stock. This represents a 66.4% upside from the current price of $21.03.
Dynavax Technologies (NASDAQ:DVAX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “sell” rating. They now have a $12.00 price target on the stock, down previously from $15.00. This represents a 2.6% downside from the current price of $12.33.
Equifax (NYSE:EFX) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating.The current price is $251.02.
Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Guggenheim from a “buy” rating to a “sell” rating. They now have a $6.00 price target on the stock, down previously from $26.00. This represents a 12.5% downside from the current price of $6.86.
Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $10.00 price target on the stock, down previously from $22.00. This represents a 45.9% upside from the current price of $6.86.
First National (NASDAQ:FXNC) was downgraded by analysts at Hovde Group from an “outperform” rating to a “market perform” rating. They now have a $28.50 price target on the stock. This represents a 9.1% upside from the current price of $26.13.
Cloudflare (NYSE:NET) was downgraded by analysts at DZ Bank AG from a “hold” rating to a “sell” rating. They now have a $145.00 price target on the stock. This represents a 15.9% downside from the current price of $172.41.
Playa Hotels & Resorts (NASDAQ:PLYA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating. They now have a $13.50 price target on the stock, down previously from $15.00. This represents a 1.8% upside from the current price of $13.26.
Playa Hotels & Resorts (NASDAQ:PLYA) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $13.26.
Q32 Bio (NASDAQ:QTTB) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $4.00 price target on the stock, down previously from $20.00. This represents a 38.6% upside from the current price of $2.89.
Q32 Bio (NASDAQ:QTTB) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $3.00 price target on the stock, down previously from $22.00. This represents a 4.0% upside from the current price of $2.89.
REGENXBIO (NASDAQ:RGNX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $14.00 price target on the stock, down previously from $38.00. This represents a 91.4% upside from the current price of $7.32.
Snap (NYSE:SNAP) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $10.70.
TechTarget (NASDAQ:TTGT) was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.The current price is $17.13.
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $22.00 price target on the stock. This represents a 19.6% upside from the current price of $18.39.
Alkermes (NASDAQ:ALKS) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $40.00 price target on the stock. This represents a 27.4% upside from the current price of $31.40.
Avadel Pharmaceuticals (NASDAQ:AVDL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $12.00 price target on the stock. This represents a 34.4% upside from the current price of $8.93.
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $176.00 price target on the stock. This represents a 32.0% upside from the current price of $133.29.
AZZ (NYSE:AZZ) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $108.00 price target on the stock. This represents a 10.7% upside from the current price of $97.57.
Biohaven (NYSE:BHVN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $65.00 price target on the stock. This represents a 63.1% upside from the current price of $39.84.
Biogen (NASDAQ:BIIB) is now covered by analysts at Sanford C. Bernstein. They set a “market perform” rating and a $160.00 price target on the stock. This represents a 13.8% upside from the current price of $140.66.
Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at TD Cowen. They set a “buy” rating on the stock.The current price is $35.68.
Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $31.00 price target on the stock. This represents a 45.9% upside from the current price of $21.25.
Domo (NASDAQ:DOMO) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $11.00 price target on the stock. This represents a 22.6% upside from the current price of $8.97.
ECARX (NASDAQ:ECX) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $3.20 price target on the stock. This represents a 61.5% upside from the current price of $1.98.
Flex (NASDAQ:FLEX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $52.00 price target on the stock. This represents a 20.5% upside from the current price of $43.15.
Gaia (NASDAQ:GAIA) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $10.00 price target on the stock. This represents a 89.8% upside from the current price of $5.27.
Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $55.00 price target on the stock. This represents a 45.5% upside from the current price of $37.81.
International Business Machines (NYSE:IBM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $320.00 price target on the stock. This represents a 26.9% upside from the current price of $252.17.
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $138.00 price target on the stock. This represents a 18.8% upside from the current price of $116.21.
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $111.00 price target on the stock. This represents a 38.2% upside from the current price of $80.35.
Silence Therapeutics (NASDAQ:SLN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “sell” rating and a $6.00 price target on the stock. This represents a 34.7% upside from the current price of $4.46.
Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $136.00 price target on the stock. This represents a 23.1% upside from the current price of $110.52.
Sunrise Realty Trust (NASDAQ:SUNS) is now covered by analysts at Keefe, Bruyette & Woods. They set an “outperform” rating and a $12.75 price target on the stock. This represents a 9.5% upside from the current price of $11.65.
TTM Technologies (NASDAQ:TTMI) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $33.00 price target on the stock. This represents a 24.3% upside from the current price of $26.54.
Waystar (NASDAQ:WAY) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $51.00 price target on the stock. This represents a 22.5% upside from the current price of $41.64.
Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $67.00 price target on the stock. This represents a 72.1% upside from the current price of $38.94.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Co. (MSFT)
